iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC) Stock Cross Above 200 Day Moving Average – Should You Sell?

iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $35.96 and traded as high as $36.65. iShares LifePath Target Date 2035 ETF shares last traded at $36.55, with a volume of 20,587 shares.

iShares LifePath Target Date 2035 ETF Stock Up 0.6%

The company has a market cap of $125.84 million, a price-to-earnings ratio of 20.04 and a beta of 0.66. The company’s fifty day moving average price is $36.62 and its two-hundred day moving average price is $35.97.

Institutional Investors Weigh In On iShares LifePath Target Date 2035 ETF

An institutional investor recently bought a new position in iShares LifePath Target Date 2035 ETF stock. Commonwealth Equity Services LLC purchased a new stake in shares of iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 6,707 shares of the company’s stock, valued at approximately $244,000. Commonwealth Equity Services LLC owned approximately 0.20% of iShares LifePath Target Date 2035 ETF at the end of the most recent reporting period.

About iShares LifePath Target Date 2035 ETF

(Get Free Report)

The iShares LifePath Target Date 2035 ETF USD (ITDC) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2035 ITDC was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Articles

Receive News & Ratings for iShares LifePath Target Date 2035 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2035 ETF and related companies with MarketBeat.com's FREE daily email newsletter.